￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What to do if you are resistant to Midostaurin

2026-02-01 22:25:32

Check Details
How long does it take for cabergoline to cause cancer?

2026-02-01 22:25:32

Check Details
Detailed requirements on usage and dosage in Platinib (Pujihua) instructions

2026-02-01 22:25:32

Check Details
What is capmatinib (Touradida) and a detailed introduction to its mechanism of action

2026-02-01 22:25:32

Check Details
Approximately how much does a course of treatment with Sotoracib (AMG 510) cost and its efficacy analysis

2026-02-01 22:25:32

Check Details
What is the response rate of adagrasib (Krazati) treatment and analysis of its impact on survival

2026-02-01 22:25:32

Check Details
Analysis of whether larotinib (Vitaika) is a targeted drug and its principle of action

2026-02-01 22:25:32

Check Details
Seleniso (Silvio) specifications and active ingredient content of each tablet

2026-02-01 22:25:32

Check Details
The best time to take Vigabatrin (Ocoda) and daily medication recommendations

2026-02-01 22:25:32

Check Details
Differences and clinical application analysis between mobosetinib (Anvili) and mobosetinib

2026-02-01 22:25:32

Check Details
Comparison of efficacy and applicable patients between Tepotinib (Tuodekang) and Capmatinib

2026-02-01 22:25:32

Check Details
Which drugs cannot be used with regorafenib (Belvango) and the potential risks

2026-02-01 22:25:32

Check Details
Category
相关知识